We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

152 hedge funds and large institutions have $796M invested in Dr. Reddy's Laboratories in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 53 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,691% more call options, than puts

Call options by funds: $394K | Put options by funds: $22K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

1% more funds holding

Funds holding: 150152 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less capital invested

Capital invested by funds: $812M → $796M (-$16.1M)

4% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 53

2.03% less ownership

Funds ownership: 65.23%63.2% (-2%)

Holders
152
Holders Change
+2
Holders Change %
+1.33%
% of All Funds
3.33%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
51
Reduced
53
Closed
16
Calls
$394K
Puts
$22K
Net Calls
+$372K
Net Calls Change
+$342K
Name Holding Trade Value Shares
Change
Change in
Stake
BCAM
76
Boston Common Asset Management
Massachusetts
$591K
Hudson Bay Capital Management
77
Hudson Bay Capital Management
Connecticut
$568K
SRAM
78
Stone Ridge Asset Management
New York
$562K +$93.3K +12,550 +20%
GH
79
GAM Holding
Switzerland
$539K
AAM
80
Advisors Asset Management
Colorado
$528K -$13.2K -1,780 -2%
PPCM
81
Pillar Pacific Capital Management
California
$517K -$10K -1,350 -2%
HDIM
82
Hanson & Doremus Investment Management
Vermont
$490K
QCG
83
Quadrant Capital Group
Ohio
$475K +$52.7K +7,085 +13%
Citigroup
84
Citigroup
New York
$473K -$374K -50,225 -45%
Geode Capital Management
85
Geode Capital Management
Massachusetts
$460K +$198K +26,630 +73%
USAA
86
United Services Automobile Association
Texas
$436K -$1.71M -230,345 -80%
PA
87
Profund Advisors
Maryland
$415K -$44.8K -6,025 -10%
AllianceBernstein
88
AllianceBernstein
Tennessee
$413K -$9.67K -1,300 -2%
LCM
89
Logan Capital Management
Pennsylvania
$403K
H
90
Hexavest
Quebec, Canada
$386K -$321K -43,110 -46%
Ameriprise
91
Ameriprise
Minnesota
$359K -$169K -22,690 -32%
AIM
92
ARGA Investment Management
Connecticut
$350K
US Bancorp
93
US Bancorp
Minnesota
$347K +$95.8K +12,875 +39%
BNP Paribas Asset Management
94
BNP Paribas Asset Management
France
$338K -$17.7K -2,385 -5%
Comerica Bank
95
Comerica Bank
Texas
$333K -$63.1K -8,490 -17%
GT
96
Greenleaf Trust
Michigan
$325K +$2.19K +295 +0.7%
OSAM
97
O'Shaughnessy Asset Management
Connecticut
$315K -$36.9K -4,960 -11%
Mirae Asset Global Investments
98
Mirae Asset Global Investments
South Korea
$314K -$7.18K -965 -2%
RHBC
99
R.H. Bluestein & Co
Michigan
$303K
Thrivent Financial for Lutherans
100
Thrivent Financial for Lutherans
Minnesota
$300K +$295K +39,620 New

RDY Hedge Fund Activity: Q3 2019 in Review

152 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2019, worth a combined $796M — down 2% from $812M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new RDY positions and 16 closed out — a net gain of 2 holders — while 51 added to existing stakes and 53 trimmed.

The largest buyer was Mitsubishi UFJ Trust & Banking, adding an estimated $15.9M. The largest seller was BlackRock, cutting an estimated $9.2M.

  • 152 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2019, up from 150 in Q2 2019.
  • Funds reported $796M of Dr. Reddy's Laboratories stock for Q3 2019, down 2% quarter-over-quarter.
  • 18 funds opened new Dr. Reddy's Laboratories positions in Q3 2019 and 16 closed out, a net change of +2 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q3 2019 was Mitsubishi UFJ Trust & Banking, an estimated $15.9M added.
  • The largest Dr. Reddy's Laboratories seller in Q3 2019 was BlackRock, an estimated $9.2M sold.

Based on aggregated 13F filings for Q3 2019.